TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light December 5, 2014
TCL Archive NCI Considers ‘Decentralization’ Of Group C To Provide Wider Access, Local Flexibility September 7, 1990
